🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

There are some big caveats, but I actually think the $ITOS $GSK Tigit data aren't all that bad. My take on today's #ESMO24 late-breaker via ApexOnco -> oncologypipeline.com/apexonco/esmo-…

There's still game for TIGIT! Promising data from iTeos Therapeutics and GSK #ESMO24

The stem cells renaissance continues in type 1 diabetes! Patient-derived islets from chemically generated iPSCs achieved sustained insulin levels for 1+ year in a clinical case study. So far n=1, w other participants reaching their 1y follow up next month. nature.com/articles/d4158…

The class of #CaixaImpulse Innovation awardees 2024 is out! It’s a pleasure to collaborate w CaixaResearch once again to foster biomedical #innovation & ignite the entrepreneurial mindset in driven academics. Looking forward to delivering my annual #VentureCapital 101 lecture!

Our latest investment in Tolerance Bio featured in FierceBiotech #portfolionews #venturecapital #biotech #financing fiercebiotech.com/biotech/new-ce…

AbbVie has acquired Aliada Therapeutics for $1.4 billion, a deal that will give the pharma control of an Alzheimer’s disease drug candidate designed to improve on the first generation of anti-amyloid-beta antibodies. fiercebiotech.com/biotech/abbvie…